Bioventus Inc. (BVS) Tops Q1 EPS by 5c ; Offers Guidance
Get Alerts BVS Hot Sheet
Join SI Premium – FREE
Bioventus Inc. (NASDAQ: BVS) reported Q1 EPS of $0.15, $0.05 better than the analyst estimate of $0.10. Revenue for the quarter came in at $132.1 million versus the consensus estimate of $129.86 million.
GUIDANCE:
Bioventus Inc. sees FY2026 EPS of $0.75-$0.79, versus the consensus of $0.75.
For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US Treasury: 'Authorizing Wind Down Activities...the Offloading of Cargo Involving Certain Persons or Vessels Blocked on October 21, 2026'
- Thermo Fisher Scientific (TMO) call put ratio 1 call to 1.9 puts with a focus on November 610 puts
- J.B. Hunt Transport Services (JBHT) Declares $0.45 Quarterly Dividend; 0.8% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share